Gayatri Ayupharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 23-10-2024
- Revenue 239.11%
(FY 2023)
- Profit 1175.03%
(FY 2023)
- Ebitda 13174.36%
(FY 2023)
- Net Worth 3162.28%
(FY 2023)
- Total Assets 70.36%
(FY 2023)
About Gayatri Ayupharma
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Dhruv Hareshkumar and Hareshkumar Patel serve as directors at the Company.
- CIN/LLPIN
U24100GJ2016PTC085691
- Company No.
085691
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Gayatri Ayupharma Private Limited offer?
Gayatri Ayupharma Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Pharmaceutical Syrup, Anti Worm Syrup, Herbal Cough Syrup, Ayurvedic Cough Syrup, Arthritic Drugs, Antacid Drugs, Allopathic Liver Tonic, Digestive System Drugs & Medicines.
Who are the key members and board of directors at Gayatri Ayupharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhruv Hareshkumar  | Director | 11-Jan-2016 | Current |
| Hareshkumar Patel | Director | 11-Jan-2016 | Current |
Financial Performance of Gayatri Ayupharma.
Gayatri Ayupharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 239.11% increase. The company also saw a substantial improvement in profitability, with a 1175.03% increase in profit. The company's net worth Soared by an impressive increase of 3162.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gayatri Ayupharma?
In 2022, Gayatri Ayupharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Dec 2023 | ₹1.00 Cr | Open |
How Many Employees Work at Gayatri Ayupharma?
Unlock and access historical data on people associated with Gayatri Ayupharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gayatri Ayupharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gayatri Ayupharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
